352 studies found for:    colorectal | Recruiting | Exclude Unknown | United States
Show Display Options
Rank Status Study
1 Recruiting Ohio Colorectal Cancer Prevention Initiative
Conditions: Lynch Syndrome;   Colorectal Cancer
Interventions: Genetic: LS tumor screening;   Genetic: Genetic testing;   Behavioral: Genetic Counseling;   Other: Biorepository;   Behavioral: Questionnaire
2 Recruiting Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Conditions: Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention: Device: Stool Sample Collection Kit
3 Recruiting Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
Condition: Colorectal Cancer
Interventions: Procedure: Colonoscopy;   Procedure: FIT
4 Recruiting Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Rectal Cancer
Intervention: Drug: IMMU-130
5 Recruiting Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients
Conditions: Lung Cancer;   Colorectal Cancer
Intervention:
6 Recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Conditions: Appendix Cancer;   Colorectal Cancer
Interventions: Procedure: Cytoreductive Surgery;   Drug: HIPEC with Mitomycin-C;   Drug: EPIC with FUDR and Leucovorin
7 Recruiting A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Xilonix;   Drug: Placebo
8 Recruiting Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma
Condition: Colorectal Carcinoma
Intervention: Drug: MGD007
9 Recruiting Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer
Conditions: Recurrent Colorectal Carcinoma;   Solid Neoplasm;   Stage IIIA Colorectal Cancer;   Stage IIIB Colorectal Cancer;   Stage IIIC Colorectal Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Drug: Cyclosporine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
10 Recruiting Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Condition: Lynch Syndrome
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Naproxen;   Other: Placebo
11 Recruiting Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Conditions: Colon Adenocarcinoma;   Rectal Adenocarcinoma;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Drug: Clobetasol Propionate;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Drug: Regorafenib
12 Recruiting Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colorectal Cancer
Condition: Colorectal Cancers
Intervention: Biological: RENCA macrobeads
13 Recruiting Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: MM-151;   Drug: nal-IRI;   Drug: Leucovorin;   Drug: 5-FU
14 Recruiting S0820, Adenoma and Second Primary Prevention Trial
Condition: Colorectal Neoplasms
Interventions: Drug: Eflornithine placebo & sulindac placebo;   Drug: eflornithine & sulindac placebo;   Drug: Eflornithine placebo & sulindac;   Drug: Eflornithine plus sulindac
15 Recruiting Regorafenib in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Regorafenib
16 Recruiting Comparative Effectiveness of CTC & OC
Condition: Colorectal Cancer
Interventions: Procedure: Optical colonoscopy;   Radiation: CT-Colonography
17 Recruiting Study of Vitamin D in Untreated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: FOLFOX + bevacizumab;   Dietary Supplement: Vitamin D
18 Recruiting A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: BBI608;   Drug: Panitumumab;   Drug: Capecitabine;   Drug: Cetuximab
19 Recruiting Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Condition: Colorectal Cancer
Interventions: Biological: cetuximab;   Biological: ramucirumab;   Drug: irinotecan hydrochloride
20 Recruiting Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Condition: Colorectal Cancer Metastatic
Intervention: Device: TheraSphere

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years